首页> 美国卫生研究院文献>Journal of Biomedical Optics >Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy

【2h】

Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy

机译：使用拉曼光谱法评估乳腺癌细胞中的HER2扩增状态和获得性耐药

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Journal of Biomedical Optics
作者
Xiaohong Bi; Brent Rexer; Carlos L. Arteaga; Mingsheng Guo; Anita Mahadevan-Jansen;
展开▼
作者单位

展开▼
年(卷),期 2014(19),2
年度 2014
页码 025001
总页数 7
原文格式 PDF
正文语种
中图分类放射医学;影像诊断学;生化遗传学;生化药理学;
关键词
Raman spectroscopy breast cancer human epidermal growth factor receptor 2 lapatinib drug resistance;

机译：拉曼光谱法;乳腺癌;人表皮生长因子受体2;拉帕替尼;耐药性;

相似文献

外文文献
中文文献
专利

1. YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers [J] . Tatsuaki Takeda, Hiromasa Yamamoto, Ken Suzawa, Cancer science. . 2020,第3期

机译：YES1激活诱导HER2-扩增的乳腺癌和肺癌中的Neratinib抗性
2. Inhibition of NOTCH signaing with g-secretase inhibitor AL101 contributes to overcome resistance against HER2-targeted therapy in HER2 amplified breast cancer cells [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：抑制与G分泌酶抑制剂AL101的抑制措施有助于克服HER2扩增乳腺癌细胞中HER2靶向治疗的抗性
3. Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells [J] . Eric Dietel, Alexander Brobeil, Claudia Tag, Oncogenesis. . 2018,第8期

机译：EGFR / HER2靶向药物的有效性受HER2扩增的乳腺癌细胞中PTPIP51下游相互作用转移的影响
4. Determination of HER2 Amplification Status in Breast Cancer Cells Using Raman Spectroscopy [C] . Xiaohong Bi, Brent Rexer, Carlos L Arteaga, Biomedical vibrational spectroscopy IV: Advances in research and industry . 2010

机译：拉曼光谱法测定乳腺癌细胞中HER2的扩增状态
5. Design and Evaluation of Peptidomimetics and Peptidomimetics Drug Conjugates Targeting HER2 Overexpressing Cells in Breast and Lung Cancers [D] . Pallerla, Sandeep. 2017

机译：拟肽和拟肽药物结合物靶向乳腺癌和肺癌中HER2过表达细胞的设计和评估
6. Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications [O] . Brent N. Rexer, Carlos L. Arteaga -1

机译：在HER2基因扩增的乳腺癌中的内在和获得抗HER2靶向疗法的抵抗力：机制和临床意义
7. Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications [O] . Brent N. Rexer, Carlos L. Arteaga 2012

机译：在HER2基因扩增的乳腺癌中的内在和获得抗HER2靶向疗法的抵抗力：机制和临床意义
8. Overcoming Resistance to Trastuzumab in HER2-Amplified Breast Cancers [R] . Moody, S. 2011

机译：克服HER2扩增乳腺癌对曲妥珠单抗的耐药性

Evaluating HER2 amplification status and acquired drug resistance in breast cancer cells using Raman spectroscopy

著录项

引文网络

相似文献

相关主题

期刊订阅